MedTrace Logo

ReIMAGINE Prostate Cancer Screening

NCT04063566 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 309

Last updated 2021-10-15

No results posted yet for this study

Summary

Single site study to assess the feasibility of prostate cancer screening using an invitation for a prostate MRI scan via GP practices. This feasibility study will assess the acceptability of an MRI as a prostate cancer screening assessment and assess the prevalence of MRI defined suspicious lesions and cancer in men across a spectrum of PSA results.

Conditions

Interventions

PROCEDURE

Magnetic Resonance Imaging (MRI)

Prostate cancer screening MRI

PROCEDURE

Prostate-specific antigen (PSA) test

Blood test for PSA levels

Sponsors & Collaborators

Principal Investigators

  • Caroline Moore, FRCS · univeristy college london

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-21
Primary Completion
2021-07-30
Completion
2021-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04063566 on ClinicalTrials.gov